Cetylpyridinium Chloride/Terbinafine

西吡氯铵/特比萘芬

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCetylpyridinium Chloride/Terbinafine
Drug Alias Name特比萘芬+西吡氯铵Terbinafine/Cetylpyridinium Chloride Hydratecetylpyridinium chloride + terbinafine特比萘芬/西吡氯铵西吡氯铵+特比萘芬 +[15
ClassificationSmall molecules
Mechanisms of ActionSqualene monooxygenase inhibitors
TargetsSqualene monooxygenase
Therapy Area/IndicationsTinea CapitisOnychomycosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBluewillow Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanobio Co
Active IndicationsN/A
Inactive IndicationsTinea CapitisOnychomycosis

Other Information

ATC CodeN/A
Related LinksN/A